Immatics (IMTX) Other Non-Current Assets (2019 - 2025)

Immatics recorded quarterly Other Non-Current Assets of $2.2 million in Q4 2025, up 124.64% quarter-over-quarter from $958625.2 in Q3 2025, and up 61.22% year-over-year from $1.3 million in Q4 2024.

Immatics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.2 million for Q4 2025.

  • In Q4 2025, Other Non-Current Assets rose 61.22% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (up 61.22% YoY), while the FY2025 annual figure was $2.1 million, up 56.48% from the prior year.
  • Other Non-Current Assets came in at $2.2 million for Q4 2025 at Immatics, up from $958625.2 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $5.0 million in Q2 2022 to a low of $710473.1 in Q1 2021.
  • A 5-year average of $1.8 million and a median of $1.4 million in 2024 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets soared 390.53% in 2022 and tumbled 56.98% in 2023, its largest moves.
  • Immatics' Other Non-Current Assets stood at $727565.5 in 2021, then jumped by 256.88% to $2.6 million in 2022, then dropped by 16.42% to $2.2 million in 2023, then plunged by 38.45% to $1.3 million in 2024, then jumped by 61.22% to $2.2 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.2 million, $958625.2, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 60,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 63.55 Mn
10 Immatics 1.80 Bn 1.80 Bn - 2.15 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.15 Mn
Sep 30, 2025 958,625.17
Jun 30, 2025 1.13 Mn
Mar 31, 2025 1.19 Mn
Dec 31, 2024 1.34 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 1.44 Mn
Mar 31, 2024 1.49 Mn
Dec 31, 2023 2.17 Mn
Sep 30, 2023 1.81 Mn
Jun 30, 2023 2.15 Mn
Mar 31, 2023 2.43 Mn
Dec 31, 2022 2.60 Mn
Sep 30, 2022 4.05 Mn
Jun 30, 2022 4.99 Mn
Mar 31, 2022 986,534.85
Dec 31, 2021 727,565.52
Sep 30, 2021 847,907.58
Jun 30, 2021 1.02 Mn
Mar 31, 2021 710,473.07
Dec 31, 2020 863,217.85
Sep 30, 2020 738,224.81
Jun 30, 2020 766,616.25
Dec 31, 2019 1.40 Mn